Key Account Director
Fennec Pharmaceuticals · key-account-director-southeast-3f4933e6a8
Normalized fields
open- Function
- digital_it
- Business unit
- Not classified
- Location
- Southeast
- Work model
- Not classified
- Seniority
- director
- Clearance
- Not provided
- Employment type
- Not provided
- Compensation
- Not provided
- First seen
- 2026-09-30T13:01:00.485Z
- Last seen
- 2026-10-12T13:00:54.270Z
- Requisition
- key-account-director-southeast-3f4933e6a8
Latest version
M A R K E T A C C E S S - O N C O L O G Y KEY ACCOUNT DIRECTOR (SOUTHEAST) ABOUT FENNEC CONTACT United States (Southeast- Florida, Puerto Rico, Georgia & Carolinas) resumes@fennecpharma.com www.fennecpharma.com NOW HIRING Fennec Pharmaceuticals Inc. is a specialty pharmaceutical company committed to the fight against ototoxicity in cancer patients who receive cisplatin-based chemotherapy. Fennec is focused on the commercialization of PEDMARK® to reduce the risk of platinum- induced ototoxicity in cancer patients. PEDMARK received FDA approval in September 2022 and European Commission approval in June 2023 and United Kingdom (U.K.) approval in October 2023 under the brand name PEDMARQSI®. In March 2024, Fennec entered into an exclusive licensing agreement under which Norgine Pharmaceuticals Ltd., a leading European specialist pharmaceutical company, will commercialize PEDMARQSI in Europe, U.K., Australia and New Zealand. PEDMARQSI is now commercially available in multiple countries. ® PEDMARK has received Orphan Drug Exclusivity in the U.S. and PEDMARQSI has received Pediatric Use Marketing Authorization in Europe which includes eight years plus two years of data and market protection. The Key Account Director (Southeast – Florida, PR, Georgia & Carolinas)- Market Access - will lead the strategic engagement with Fennec’s most important oncology customer accounts. KAD (Southeast) is responsible and accountable for the build and pull-through of PEDMARK® strategic plans for the largest community oncology practices & Academic institutions. KAD team will effectively communicate and collaborate with market access, marketing, product strategy, sales and medical affairs team members to identify opportunities and reduce barriers to accessing and pulling through clinical utilization of Fennec’s key product PEDMARK® This role will report to the Vice President, Head of Market Access. POSITION SUMMARY Are you a motivated and results-driven professional? Do you thrive in entrepreneurial environments? Are you ready to be part of a high- performing team that addresses significant unmet patient needs? Apply to join Fennec and be a part of our important mission for patients and healthcare professionals! Apply Now! Focus on strategic engagement with Fennec’s most important oncology customer accounts Comprehensive development of strong customer management and strategic relationships with C-suite and senior management stakeholders within largest community oncology practices, academic institutions, and GPO accounts to create and execute a top- down/bottom-up strategy Establish and maintain an in-depth understanding of key account needs, challenges, priorities, opportunities, and effectively communicate key intelligence of customer and industry trends to internal partners and stakeholders. Evaluate markets and customers to identify and develop opportunities that support the growth of PEDMARK® Analyze product volume, trends, and growth, for assigned accounts. Develop and implement account level business plans and work with product strategy to develop segment strategies and resources Build and develop strategic pull-through plans for key national and regional accounts. Support the problem solving for account opportunities. Responsible and accountable for managing and monitoring the budget, ensuring effective investment and spend Lead GPO contract execution and account performance tracking Effectively communicate and collaborate cross-functionally with all of market access, marketing, product strategy, sales, and medical affairs team members to identify opportunities and reduce barriers to accessing PEDMARK® within the largest community oncology practices & institutions within the nation RESPONSIBILITIES OUR NAME Click To Learn More About Cisplatin-Induced Hearing Loss Family Stories PEDMARK (sodium thiosulfate) Communicate appropriately with our medical affairs & marketing teams regarding account specific needs Coordinate and actively participate in appropriate customer & industry meetings. Identify team and account needs and work with market access leadership and cross functional teams to develop resources that address the needs of the commercial business at the account level Develop quarterly business review presentation demonstrating the achievements of key metrics, budget review, and strategic planning exercises Performs all company business compliantly and in accordance with company policies and procedures Extensive experience in the pharmaceutical/biotech industry, oncology experience required Strong understanding of the US market access landscape and the legal/regulatory environment for pharmaceuticals/biopharmaceuticals In-depth knowledge of oncology distribution, patient access and reimbursement, managed care/federal/state marketplace sectors, and provider/physician networks Thorough understanding including previous relationships with geographic specific key strategic customers and knowledge of industry marketing practices and trends Demonstrated strategic thinking, problem-solving, analytical, critical thinking, and planning skills. Experience developing/implementing a strategy preferred. Initiative-taking nature and ability to manage change, anticipate risks, and design controls or mitigation Excellent leadership and communication skills (written & verbal) Proficient at leading diverse roles and effectively engaging senior management Strong judgment, prioritization, and decision-making skills, with an understanding of the broader context of corporate strategies Comfort and confidence in engaging with diverse teams and backgrounds; routinely demonstrate inclusive behaviors; actively seeks out diverse perspectives and experiences Demonstrated understanding of healthcare trends and policy issues around pharmacy and medical benefits and their potential impact on the company's business opportunities Up to 75% Travel RESPONSIBILITIES (continued) QUALIFICATONS We proudly take our name from the fennec fox, a distinctively large-eared canine that is the smallest of all fox species. Fennec foxes roam the sandy Sahara and greater North African region. Their characteristic ears serve a dual purpose: they are sensitive enough to hear prey underground and also help dissipate the hot desert heat. Children undergoing chemotherapy are going through an extraordinarily challenging time, and the loss of hearing only compounds the difficulty. Fennec Pharma, named after that resourceful and determined fennec fox, is committed to helping children at risk of hearing loss due to ototoxicity. EDUCATION REQUIREMENTS Required: Bachelor's degree (BA/BS) Preferred: Master's degree (MBA) and/or advance clinical degree RN, NP, PA PREFERRED EXPERIENCE Strong understanding of the US market access landscape Experience developing and implementing a strategy Managed care/payer experience Customer-facing experience We understand compensation is an important factor as you consider the next step in your career. Below is an overview of the compensation and benef its offerings. Base salary range: $200,000-$260,000 The estimated salary range reflects an anticipated range for this position. The actual base salary offered may depend on a variety of factors, including the qualif ications of the individual applicant for the position, years of relevant experience, specif ic and unique skills, level of education attained, certif ications or other professional licenses held. Employees may be eligible to participate in medical, dental, vision insurance, a 401(k) plan, short-term and long-term disability coverage, basic life insurance, company holidays, vacation, cell phone and WiFi reimbursement, a bonus, and stock options. COMPENSATION AND BENEFITS SUMMARY
Derived classifications
{
"programs": [],
"geography": [
{
"value": "Southeast",
"evidence": [
"Southeast"
],
"confidence": "high"
}
],
"facilities": [],
"entities_programs": [],
"business_categories": [
{
"value": "digital_it",
"evidence": [
"iatric Use Marketing Authorization in Europe which includes eight years plus two years of data and market protection. The Key Account Director (Southeast – Florida, PR, Georgia & Carol"
],
"confidence": "high"
},
{
"value": "intelligence",
"evidence": [
"key account needs, challenges, priorities, opportunities, and effectively communicate key intelligence of customer and industry trends to internal partners and stakeholders. Evaluate markets a"
],
"confidence": "high"
},
{
"value": "corporate",
"evidence": [
"ioritization, and decision-making skills, with an understanding of the broader context of corporate strategies Comfort and confidence in engaging with diverse teams and backgrounds; routine",
"cology experience required Strong understanding of the US market access landscape and the legal/regulatory environment for pharmaceuticals/biopharmaceuticals In-depth knowledge of oncol"
],
"confidence": "high"
}
]
}Version history
2 retained{
"added": [
"is a specialty pharmaceutical company committed to the fight against ototoxicity in cancer patients who receive cisplatin-based chemotherapy.",
"Fennec is focused on the commercialization of PEDMARK® to reduce the risk of platinum- induced ototoxicity in cancer patients.",
"PEDMARK received FDA approval in September 2022 and European Commission approval in June 2023 and United Kingdom (U.K.) approval in October 2023 under the brand name PEDMARQSI®.",
"In March 2024, Fennec entered into an exclusive licensing agreement under which Norgine Pharmaceuticals Ltd., a leading European specialist pharmaceutical company, will commercialize PEDMARQSI in Europe, U.K., Australia and New Zealand.",
"PEDMARQSI is now commercially available in multiple countries.",
"® PEDMARK has received Orphan Drug Exclusivity in the U.S.",
"KAD (Southeast) is responsible and accountable for the build and pull-through of PEDMARK® strategic plans for the largest community oncology practices & Academic institutions.",
"KAD team will effectively communicate and collaborate with market access, marketing, product strategy, sales and medical affairs team members to identify opportunities and reduce barriers to accessing and pulling through clinical utilization of Fennec’s key product PEDMARK® This role will report to the Vice President, Head of Market Access."
],
"removed": [
"is a specialty pharmaceutical company focused on the development and commercialization of PEDMARK® to reduce the risk of platinum- induced ototoxicity in pediatric patients.",
"Further, PEDMARK® received FDA approval in September 2022 and European Commission approval in June 2023 and U.K.",
"approval in October 2023 under the brand name PEDMARQSI®.",
"PEDMARK has received Orphan Drug Exclusivity in the U.S.",
"Fennec employees are expected to embrace diversity, and be able to work with internal and external partners from a variety of backgrounds, and experiences.",
"Additionally, the successful candidate must demonstrate excellence in integrity and compliance with all interactions and adherence to corporate and industry guidelines.",
"Fennec offers a fun, friendly, and industry competitive environment.",
"KAD (Southeast) is responsible and accountable for the build and pull- through of PEDMARK® strategic plans for the largest community oncology practices & Academic institutions.KAD team will effectively communicate and collaborate with market access, marketing, product strategy, sales and medical affairs team members to identify opportunities and reduce barriers to accessing and pulling through clinical utilization of Fennec’s key product PEDMARK® This role will report to the Vice President, Head of Market Access."
]
}